We found a preventive effect (fewer behavioral symptoms at 4 months for TAP-VA participants than controls), a maintenance effect (TAP-VA caregivers provided assistance with a similar number of ADLs at 4 months whereas controls reported increases in assistance required), reductions in frequency by severity of behaviors and pain, and slowing of functional dependence. TAP-VA also benefited caregivers by reducing distress with behavior.Results are consistent with those of other TAP trials (initial pilot, TAP-hospital,22 TAP Brazil,23 TAP-Australia),24 extending reported benefits to pain and functional dependence. It is disappointing that 4-month benefits did not endure to 8 months, yet expectations for long-term effects may be unrealistic without repeated exposure to the treatment (activity engagement). Unlike pharmacotherapies, activity use depends upon caregivers. We could not determine whether caregivers discontinued activity use or activities needed modifications.
We found a preventive effect (fewer behavioral symptoms at 4 months for TAP-VA participants than controls), a maintenance effect (TAP-VA caregivers provided assistance with a similar number of ADLs at 4 months whereas controls reported increases in assistance required), reductions in frequency by severity of behaviors and pain, and slowing of functional dependence. TAP-VA also benefited caregivers by reducing distress with behavior.<br>Results are consistent with those of other TAP trials (initial pilot, TAP-hospital,22 TAP Brazil,23 TAP-Australia),24 extending reported benefits to pain and functional dependence. <br>令人失望的是4個月的收益並沒有承受到8個月,但對長期影響的預期可能無需反复暴露於處理(活動參與)是不現實的。不像藥物療法,活動中使用取決於護理人員。我們無法確定護理人員中止活動中使用或活動是否需要修改。
正在翻譯中..